ICD-10-CM Billable Code

C71.1

Malignant neoplasm of frontal lobe

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the frontal lobe refers to a type of brain cancer located in the frontal part of the brain. This condition involves uncontrolled growth of abnormal cells, which can interfere with vital brain functions. The frontal lobe is responsible for important activities such as decision-making, problem-solving, controlling behavior, and voluntary muscle movements. When a malignant tumor occurs here, it can significantly impact these functions and poses serious health concerns.

Causes & Symptoms

Clinical Causes: Genetic mutations within brain cells that lead to uncontrolled growth Exposure to high doses of radiation or carcinogenic substances Family history of brain tumors (although rare) Pre-existing conditions or other cancers that may spread to the brain Age-related genetic changes, as such tumors are more common in older adults

Key Symptoms: Persistent headaches that worsen over time Seizures or convulsions Changes in personality or behavior, such as increased irritability, apathy, or impulsiveness Weakness or paralysis on one side of the body Difficulty with speech or language comprehension Problems with coordination or balance Visual disturbances, such as blurred vision or loss of sight in one eye Memory issues or difficulty concentrating

Diagnostic & Treatment

Diagnosis Path: Diagnosis of a malignant neoplasm in the frontal lobe typically involves a combination of medical evaluations and diagnostic tests. Medical history and physical examinations help identify neurological deficits and symptoms. Imaging studies such as MRI (Magnetic Resonance Imaging) and CT (Computed Tomography) scans are essential to visualize the tumor. A biopsy, which involves extracting a tissue sample for laboratory analysis, provides definitive evidence of malignancy. In some cases, additional tests like neurological assessments or advanced imaging techniques may be employed to assess the extent of the tumor and its impact on the brain.

Treatment Protocols: Treatment options depend on the tumor's size, location, and malignancy level. Common approaches include: - Surgery: The primary treatment often involves surgical removal of as much of the tumor as possible. - Radiation therapy: High-energy beams are used to target and destroy cancer cells remaining after surgery or when surgery isn't feasible. - Chemotherapy: Systemic drug treatments may be used to kill cancer cells or slow their growth. - Targeted therapy and immunotherapy: Emerging treatments aimed at specific molecular targets or enhancing the immune response. - Supportive care: Rehabilitation, symptom management, and palliative care to improve quality of life. A multidisciplinary medical team customizes treatment plans based on individual patient needs and the tumor's characteristics.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C71.1 a billable ICD-10 code?
Yes, C71.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C71.1?
Clinical documentation must specify the nature of Malignant neoplasm of frontal lobe and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

frontal neoplasm malignant